Related Experiment Video
Updated: Aug 8, 2026
07:49
Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
[Myambutol (ethambutol)-induced retinoneuritis]
Klinische Monatsblatter Fur Augenheilkunde
|July 1, 1985
Summary
Ethambutol (Myambutol) can cause vision loss, affecting optic nerves and retina. Vision may recover after stopping treatment, but severe cases may result in permanent vision impairment.
Area of Science:
- Ophthalmology
- Neurology
- Pharmacology
Background:
- Ethambutol is a first-line medication for tuberculosis treatment.
- Ocular toxicity is a known side effect of ethambutol therapy.
Observation:
- Retinoneuritis occurred with ethambutol doses exceeding 20 mg/kg/day.
- Visual acuity deterioration happened within 6 months of treatment initiation, persisting even after drug discontinuation.
- Clinical signs included reddish optic discs, retinal hemorrhages, and macular pigment alterations.
Findings:
- Vision recovery varied, taking 2 to 16 months post-deterioration onset.
- Prognosis was poor for vision loss to 1/10 or less, with little improvement.
- Vision loss to 0.3-0.4 typically resulted in full recovery.
Implications:
- Early detection and monitoring of ethambutol-induced ocular toxicity are crucial.
- Understanding the clinical presentation aids in differentiating toxic retinoneuritis from optic neuritis.
- Electrophysiological findings support a toxic etiology for the observed visual disturbances.
